Mohammed A.W. Elkhatib

Amelioration of perivascular adipose inflammation reverses vascular dysfunction in a model of nonobese prediabetic metabolic challenge: potential role of antidiabetic drugs

Mohammed A.W. Elkhatib, Ali Mroueh, Rim W. Rafeh et al. · Translational research · 2019 · 38 citations

Medicine, Endocrinology, Pharmacology +17

Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function

Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 34 citations · Full text

Life Sciences, Pharmacology, Physiology +17

A Novel HPLC-DAD Method for Simultaneous Determination of Febuxostat and Diclofenac in Biological Samples: Pharmacokinetic Outcomes

Fawzy A. El‐Yazbi, Omayma A. Amin, Eman I. El‐Kimary et al. · Bioanalysis · 2018 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Green analytical method for the determination of sofosbuvir, ledipasvir, ribavirin and complex silymarin flavonoids simultaneously in biological fluids

Amira F. El‐Yazbi, Yasmine Khalifa, Mohammed A.W. Elkhatib et al. · Microchemical Journal · 2021 · 19 citations

Pharmacy, Pharmaceutical Analysis, Pharmacokinetics +12

Gradient HPLC-DAD method for quantification of novel oral anticoagulant “Edoxaban” in plasma: Its selective determination in presence of sixteen co-administered drugs

Sameh E. Younis, Sara A. El-Nahass, Mohammed A.W. Elkhatib et al. · Journal of Chromatography B · 2020 · 14 citations

Medicine, Pharmaceutical Analysis, Pharmacology +13